In this blog, Sarah Carr examines a systematic review into the psychosocial factors that help and hinder mental health recovery and discusses implications for policy.
[read the full story...]
Sally Adams appraises and summarises the SCIMITAR pilot RCT, which investigates smoking cessation for people with severe mental ill health. The paper presents a highly promising bespoke intervention for smokers with bipolar disorder, psychosis or schizophrenia.
[read the full story...]
Marcus Munafò looks at the mounting evidence about smoking and risk of schizophrenia, including a new case-control study that provides clear evidence of a prospective association between cigarette smoking and a subsequent diagnosis of schizophrenia.
[read the full story...]
Andrew Shepherd reports on a recent systematic review, meta-analysis and reappraisal of Quetiapine for schizophrenia, which concludes that Quetiapine IR has a small beneficial effect on psychotic symptoms, but also leads to weight gain and sedation.
[read the full story...]
Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015
[read the full story...]
David Steele summarises a review of systematic reviews and meta-analyses, which looks at the mediators and moderators of the placebo effect in psychiatry.
[read the full story...]
Meg Fluharty summarises a recent clinical overview of smoking cessation in people with severe mental illness, which provides useful practical advice to clinicians who are trying to help service users with schizophrenia, psychosis and other conditions to quit smoking
[read the full story...]
In her debut blog, Tracey Roberts summarises a recent meta-analysis which asks: Do negative symptoms of schizophrenia change over time?
[read the full story...]
John Baker reviews a recent participant-level meta-analysis of six placebo-controlled studies, which looks at the initial severity of schizophrenia and the efficacy of antipsychotics including Olanzapine, Risperidone and Amisulpride.
[read the full story...]
Raluca Lucacel writes her debut blog about an age-period-cohort analysis, which investigates how attitudes towards people with mental illness worsen during the course of life.
[read the full story...]
